Speaker illustration

Miss Aline Wartanian

Karolinska University Hospital, Stockholm (Sweden)

DOAC versus warfarin in patients with atrial fibrillation and stage IV-V chronic kideny disease including patients on dialysis.

Event: ESC Congress 2021 - The Digital Experience

Topic: Oral Anticoagulation

Session: Atrial fibrillation e-posters


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb